2024
‘Exerkines’: A Comprehensive Term for the Factors Produced in Response to Exercise
Novelli G, Calcaterra G, Casciani F, Pecorelli S, Mehta J. ‘Exerkines’: A Comprehensive Term for the Factors Produced in Response to Exercise. Biomedicines 2024, 12: 1975. PMID: 39335489, PMCID: PMC11429193, DOI: 10.3390/biomedicines12091975.Peer-Reviewed Original ResearchPhysical activityMuscle adaptationBenefits of physical trainingMultiple benefits of exerciseBenefits of exerciseEffects of exerciseRegular exerciseLifestyle factorsPhysical exercisePhysical trainingExerkinesExerciseDisease burdenHealthPrevent diseaseHealth implicationsHealth benefitsClinical course of diseaseCourse of diseaseTissue adaptationPharmacological therapyMuscleClinical courseAutocrine pathwayMetabolic regulation
2023
Letter to the Editor: 2023 FIGO staging system for endometrial cancer
Raspagliesi F, Creasman W, Bogani G, Pecorelli S. Letter to the Editor: 2023 FIGO staging system for endometrial cancer. International Journal Of Gynecology & Obstetrics 2023, 164: 366-368. PMID: 38055222, DOI: 10.1002/ijgo.15266.Peer-Reviewed Original ResearchCOVID-19 vaccine literacy: A scoping review
Biasio L, Zanobini P, Lorini C, Monaci P, Fanfani A, Gallinoro V, Cerini G, Albora G, Del Riccio M, Pecorelli S, Bonaccorsi G. COVID-19 vaccine literacy: A scoping review. Human Vaccines & Immunotherapeutics 2023, 19: 2176083. PMID: 36794338, PMCID: PMC10026896, DOI: 10.1080/21645515.2023.2176083.Peer-Reviewed Original Research
2021
Italian Adults’ Likelihood of Getting COVID-19 Vaccine: A Second Online Survey
Biasio L, Bonaccorsi G, Lorini C, Mazzini D, Pecorelli S. Italian Adults’ Likelihood of Getting COVID-19 Vaccine: A Second Online Survey. Vaccines 2021, 9: 268. PMID: 33802873, PMCID: PMC8002675, DOI: 10.3390/vaccines9030268.Peer-Reviewed Original ResearchCOVID-19 vaccineCOVID-19 vaccine developmentPercentage of participantsRapid online surveyItalian adultsInfectious disease outbreaksVaccine literacyVaccine developmentSame questionnaireSecond online surveyOnline surveyCOVID-19Similar populationsCategorical scaleEarly phaseAdultsDisease outbreaksLiteracy levelsVaccinationVaccinePublic knowledge
2020
Assessing COVID-19 vaccine literacy: a preliminary online survey
Biasio L, Bonaccorsi G, Lorini C, Pecorelli S. Assessing COVID-19 vaccine literacy: a preliminary online survey. Human Vaccines & Immunotherapeutics 2020, 17: 1304-1312. PMID: 33118868, PMCID: PMC8078752, DOI: 10.1080/21645515.2020.1829315.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccine literacyCOVID-19 vaccine candidatesFuture COVID-19 vaccineValue of immunizationMean functional scoreHealth literacy skillsCOVID-19 vaccineRapid online surveyFunctional scoresVL levelsCurrent vaccinationInfectious disease outbreaksSelf-report toolVaccine literacyGeneral populationHealth literacyVaccine candidatesVaccinationScientific evidenceOnline surveyDisease outbreaksScoresCOVID-19 InfodemicPreliminary online surveyImmunization
2006
Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Beller U, Quinn M, Benedet J, Creasman W, Ngan H, Maisonneuve P, Pecorelli S, Odicino F, Heintz A. Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s7-27. PMID: 17161169, DOI: 10.1016/s0020-7292(06)60028-3.Peer-Reviewed Original ResearchAdolescentAdultAge DistributionAgedAged, 80 and overCarcinomaCombined Modality TherapyDisease-Free SurvivalFemaleGlobal HealthHumansInternational CooperationKaplan-Meier EstimateMedical Records Systems, ComputerizedMiddle AgedNeoplasm InvasivenessNeoplasm StagingSocieties, MedicalVulvar NeoplasmsWomen's HealthCarcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Beller U, Benedet J, Creasman W, Ngan H, Quinn M, Maisonneuve P, Pecorelli S, Odicino F, Heintz A. Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s29-42. PMID: 17161165, DOI: 10.1016/s0020-7292(06)60029-5.Peer-Reviewed Original ResearchAdolescentAdultAge DistributionAgedAged, 80 and overCarcinomaCombined Modality TherapyDisease-Free SurvivalFemaleGlobal HealthHumansInternational CooperationKaplan-Meier EstimateMedical Records Systems, ComputerizedMiddle AgedNeoplasm InvasivenessNeoplasm StagingSocieties, MedicalVaginal NeoplasmsWomen's HealthCarcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Quinn M, Benedet J, Odicino F, Maisonneuve P, Beller U, Creasman W, Heintz A, Ngan H, Pecorelli S. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s43-103. PMID: 17161167, DOI: 10.1016/s0020-7292(06)60030-1.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge DistributionAgedAged, 80 and overCarcinomaCombined Modality TherapyDisease-Free SurvivalFemaleGlobal HealthHumansInternational CooperationKaplan-Meier EstimateMedical Records Systems, ComputerizedMiddle AgedNeoplasm InvasivenessNeoplasm StagingProportional Hazards ModelsSocieties, MedicalUterine Cervical DysplasiaUterine Cervical NeoplasmsWomen's HealthCarcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Creasman W, Odicino F, Maisonneuve P, Quinn M, Beller U, Benedet J, Heintz A, Ngan H, Pecorelli S. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s105-43. PMID: 17161155, DOI: 10.1016/s0020-7292(06)60031-3.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge DistributionAgedAged, 80 and overCarcinomaCombined Modality TherapyDilatation and CurettageDisease-Free SurvivalFemaleGlobal HealthHumansInternational CooperationKaplan-Meier EstimateMedical Records Systems, ComputerizedMiddle AgedNeoplasm InvasivenessNeoplasm StagingProportional Hazards ModelsSocieties, MedicalUterine NeoplasmsWomen's HealthCarcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Heintz A, Odicino F, Maisonneuve P, Quinn M, Benedet J, Creasman W, Ngan H, Pecorelli S, Beller U. Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s145-60. PMID: 17161156, DOI: 10.1016/s0020-7292(06)60032-5.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge DistributionAgedAged, 80 and overCarcinomaCombined Modality TherapyDisease-Free SurvivalFallopian Tube NeoplasmsFemaleGlobal HealthHumansInternational CooperationKaplan-Meier EstimateMedical Records Systems, ComputerizedMiddle AgedNeoplasm InvasivenessNeoplasm StagingProportional Hazards ModelsSocieties, MedicalWomen's HealthGestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Ngan H, Odicino F, Maisonneuve P, Creasman W, Beller U, Quinn M, Heintz A, Pecorelli S, Benedet J. Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s193-203. PMID: 17161158, DOI: 10.1016/s0020-7292(06)60034-9.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge DistributionAgedAged, 80 and overCombined Modality TherapyDisease-Free SurvivalFemaleGestational Trophoblastic DiseaseGlobal HealthHumansInternational CooperationKaplan-Meier EstimateLymphatic MetastasisMedical Records Systems, ComputerizedMiddle AgedNeoplasm InvasivenessNeoplasm StagingPregnancyPregnancy Complications, NeoplasticProportional Hazards ModelsSocieties, MedicalWomen's HealthWhy Cancer Staging?
BENEDET J, PECORELLI S. Why Cancer Staging? International Journal Of Gynecology & Obstetrics 2006, 95: s3-s3. PMID: 29644672, DOI: 10.1016/s0020-7292(06)60026-x.Peer-Reviewed Original ResearchCarcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Heintz A, Odicino F, Maisonneuve P, Quinn M, Benedet J, Creasman W, Ngan H, Pecorelli S, Beller U. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal Of Gynecology & Obstetrics 2006, 95 Suppl 1: s161-92. PMID: 17161157, DOI: 10.1016/s0020-7292(06)60033-7.Peer-Reviewed Original ResearchAdolescentAdultAge DistributionAgedAged, 80 and overCarcinomaCombined Modality TherapyDisease-Free SurvivalFemaleGlobal HealthHumansInternational CooperationKaplan-Meier EstimateLymphatic MetastasisMedical Records Systems, ComputerizedMiddle AgedNeoplasm InvasivenessNeoplasm StagingOvarian NeoplasmsProportional Hazards ModelsSocieties, MedicalWomen's Health0348: Phase I Dose Escalation Trial of Hpv16/18 E7-Pulsed Dendritic Cell Vaccination in Stage Ib-Iia Cervical Cancer Patients
Santin A, Bellone S, Palmieri M, Ravaggi A, Zanolini A, Roman J, Burnett A, Cannon M, Pecorelli S. 0348: Phase I Dose Escalation Trial of Hpv16/18 E7-Pulsed Dendritic Cell Vaccination in Stage Ib-Iia Cervical Cancer Patients. International Journal Of Gynecological Cancer 2006, 16: 699.3-699. DOI: 10.1136/ijgc-00009577-200610001-00348.Peer-Reviewed Original Research0009: Extending the Platinum-Free Interval (PFI) with a Non-Platinum Therapy in Platinum (P)-Sensitive Recurrent Ovarian Cancer (Oc): Results From the Socrates Retrospective Study
Odicino F, Katsaros D, Pignata S, Scambia G, Cormio G, Stellato G, Scollo P, Costa B, Magni G, Iaffaioli R, Pecorelli S. 0009: Extending the Platinum-Free Interval (PFI) with a Non-Platinum Therapy in Platinum (P)-Sensitive Recurrent Ovarian Cancer (Oc): Results From the Socrates Retrospective Study. International Journal Of Gynecological Cancer 2006, 16: 601.3-601. DOI: 10.1136/ijgc-00009577-200610001-00009.Peer-Reviewed Original Research0047: Claudin-3 and Claudin-4 Receptor Overexpression: Novel Targets for a Type Specific Therapy Against Uterine Serous Papillary Carcinomas Using Clostridium Perfringens Enterotoxin
Santin A, Bandiera E, Comper F, Bellone M, Marizzoni S, Zanolini A, Palmieri M, Siegel E, Mckinney J, Thomas M, Hennings L, Roman J, Burnett A, Cannon M, Pecorelli S. 0047: Claudin-3 and Claudin-4 Receptor Overexpression: Novel Targets for a Type Specific Therapy Against Uterine Serous Papillary Carcinomas Using Clostridium Perfringens Enterotoxin. International Journal Of Gynecological Cancer 2006, 16: 612.2-612. DOI: 10.1136/ijgc-00009577-200610001-00047.Peer-Reviewed Original Research0178: Oral Gimatecan in Women with Progressing or Recurring Advanced Epithelial Ovarian, Fallopian Tube and Peritoneal Cancers
Pecorelli S, Ray-Coquard I, Colombo N, Parma G, Tognon G, Katsaros D, Lhomme C, Lissoni A, Vermorken J, Du Bois A, Poveda A, Frigerio L, Guastalla J. 0178: Oral Gimatecan in Women with Progressing or Recurring Advanced Epithelial Ovarian, Fallopian Tube and Peritoneal Cancers. International Journal Of Gynecological Cancer 2006, 16: 650.1-650. DOI: 10.1136/ijgc-00009577-200610001-00178.Peer-Reviewed Original Research
2005
00099 THE SURVIVAL BENEFIT OF INTERVAL DEBULKING SURGERY (IDS) IN ADVANCED OVARIAN CANCER IS MAINTAINED DURING TEN YEARS; THE EORTC GCG 55865 STUDY
van der Burg M, Coens C, van Lent M, Kobierska A, Colombo N, Favalli G, Lacava A, Theodorovic I, Pecorelli S. 00099 THE SURVIVAL BENEFIT OF INTERVAL DEBULKING SURGERY (IDS) IN ADVANCED OVARIAN CANCER IS MAINTAINED DURING TEN YEARS; THE EORTC GCG 55865 STUDY. International Journal Of Gynecological Cancer 2005, 15: 79.1-79. DOI: 10.1136/ijgc-00009577-200509001-00099.Peer-Reviewed Original Research00086 ANALYSIS OF GENE EXPRESSION PATTERNS THAT DEFINES SEROUS PAPILLARY OVARIAN CARCINOMAS
Bignotti E, Tassi R, Calza S, Ravaggi A, Romani C, Rossi E, Donzelli C, Falchetti M, Pasinetti B, Odicino F, Pecorelli S, Santin A. 00086 ANALYSIS OF GENE EXPRESSION PATTERNS THAT DEFINES SEROUS PAPILLARY OVARIAN CARCINOMAS. International Journal Of Gynecological Cancer 2005, 15: 75.2-75. DOI: 10.1136/ijgc-00009577-200509001-00086.Peer-Reviewed Original Research
2004
GENE EXPRESSION FINGERPRINT OF UTERINE SEROUS PAPILLARY CARCINOMA: IDENTIFICATION OF NOVEL MOLECULAR MARKERS FOR UTERINE SEROUS CANCER DIAGNOSIS AND THERAPY
Santin A, Bellone S, Cane' S, Palmieri M, Bignotti E, Anfossi S, Thomas M, Roman J, Kay H, Burnett A, O'Brien T, Cannon M, John S, Zhan F, Tian E, Pecorelli S. GENE EXPRESSION FINGERPRINT OF UTERINE SEROUS PAPILLARY CARCINOMA: IDENTIFICATION OF NOVEL MOLECULAR MARKERS FOR UTERINE SEROUS CANCER DIAGNOSIS AND THERAPY. International Journal Of Gynecological Cancer 2004, 14: 2.3-2. DOI: 10.1136/ijgc-00009577-200409001-00006.Peer-Reviewed Original Research